PIK3CA c.1457T>C ;(p.F486S)

Variant ID: 3-178928271-T-C

NM_006218.2(PIK3CA):c.1457T>C;(p.F486S)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: PI3K: F486S
PubMed Link: 35229492
Variant Present in the following documents:
  • PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page



PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Ilic, Nina N; Utermark, Tamara T; Widlund, Hans R HR; Roberts, Thomas M TM
Publication Date: 2011-09-13

Variant appearance in text: PIK3CA: F486S
PubMed Link: 21876152
Variant Present in the following documents:
  • Main text
View BVdb publication page



Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Therapeutics And Clinical Risk Management
Henkes, Martin M; van der Kuip, Heiko H; Aulitzky, Walter E WE
Publication Date: 2008-02

Variant appearance in text: PI3K: Phe486Ser
PubMed Link: 18728706
Variant Present in the following documents:
  • Main text
  • tcrm-0401-163.pdf
View BVdb publication page